105 related articles for article (PubMed ID: 11078121)
1. The screening history of women with cervical cancer in the Rotterdam area.
Kreuger FA; Beerman H
Eur J Epidemiol; 2000; 16(7):641-5. PubMed ID: 11078121
[TBL] [Abstract][Full Text] [Related]
2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
3. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
Othman NH; Devi BC; Halimah Y
Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.
Makino H; Sato S; Yajima A; Komatsu S; Fukao A
Tohoku J Exp Med; 1995 Mar; 175(3):171-8. PubMed ID: 7792786
[TBL] [Abstract][Full Text] [Related]
6. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
7. Implementing the national invasive cervical cancer audit: a local perspective.
Moss EL; Pearmain P; Askew S; Owen G; Reynolds TM; Prabakar IM; Douce G; Parkes J; Menon V; Todd RW; Redman CW
BJOG; 2010 Oct; 117(11):1411-6. PubMed ID: 20716252
[TBL] [Abstract][Full Text] [Related]
8. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
9. 1991 cervical screening recommendations: a working group report.
Paul C; Bagshaw S; Bonita R; Durham G; Fitzgerald NW; Jones RW; Marshall B; McAvoy BR
N Z Med J; 1991 Jul; 104(915):291-5. PubMed ID: 1906587
[TBL] [Abstract][Full Text] [Related]
10. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
11. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
Boon ME; de Graaff Guilloud JC; Rietveld WJ; Wijsman-Grootendorst A
Cytopathology; 1990; 1(4):201-10. PubMed ID: 2101670
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
13. The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist?
Kenter GG; Schoonderwald EM; Koelma IA; Arentz N; Hermans J; Fleuren GJ
Acta Obstet Gynecol Scand; 1996 Apr; 75(4):400-3. PubMed ID: 8638464
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening: spatial associations of outcome and risk factors in Rotterdam.
Kreuger FA; van Oers HA; Nijs HG
Public Health; 1999 May; 113(3):111-5. PubMed ID: 10910407
[TBL] [Abstract][Full Text] [Related]
15. Papanicolaou smear screening interval and risk of cervical cancer.
Shy K; Chu J; Mandelson M; Greer B; Figge D
Obstet Gynecol; 1989 Dec; 74(6):838-43. PubMed ID: 2586947
[TBL] [Abstract][Full Text] [Related]
16. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence.
Zappa M; Visioli CB; Ciatto S; Iossa A; Paci E; Sasieni P
Br J Cancer; 2004 May; 90(9):1784-6. PubMed ID: 15150597
[TBL] [Abstract][Full Text] [Related]
17. Population screening for cervical cancer in the region of Nijmegen, The Netherlands 1976-1985.
van der Graaf Y; Vooijs PG; Zielhuis GA
Gynecol Oncol; 1988 Jul; 30(3):388-97. PubMed ID: 3391422
[TBL] [Abstract][Full Text] [Related]
18. Screening history of women in Malmö with invasive cervical cancer.
Lindqvist PG; Hellsten C; Rippe A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
[TBL] [Abstract][Full Text] [Related]
19. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
20. False negative rate in mass screening for cervical cancer.
Sato S; Mikino H; Matsunaga G; Yajima A
Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
